Hansa Biopharma Year-end report January-December 2023 ...Middle East

News by : (PR Newswire) -
Strong revenue generation in Q4 2023 including SEK 43m in Idefirix® product sales supported by growth in new markets such as U.K., Germany, and Spain Encouraging results from first-in-human trial of HNSA-5487 Initiation of phase 1b trial of imlifidase as pre-treatment to Sarepta's...

Hence then, the article about hansa biopharma year end report january december 2023 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hansa Biopharma Year-end report January-December 2023 )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار